首页> 外文期刊>Urologic oncology >Management of isolated renal fossa recurrence following radical nephrectomy Master VA, Gottschalk AR, Kane C, Carroll PR, Department of Urology, Department of Radiation Oncology, University of California, San Francisco, CA.
【24h】

Management of isolated renal fossa recurrence following radical nephrectomy Master VA, Gottschalk AR, Kane C, Carroll PR, Department of Urology, Department of Radiation Oncology, University of California, San Francisco, CA.

机译:根治性肾切除术后孤立性肾窝复发的处理Master VA,Gottschalk AR,Kane C,Carroll PR,泌尿外科,放射科,加利福尼亚大学,旧金山,CA。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: Local recurrence of renal cell carcinoma in the renal fossa without distant metastatic disease is an infrequent occurrence. Management of this lesion can be challenging, with relatively few series in the literature. We describe our use of surgical extirpation with adjuvant intraoperative radiation. MATERIALS AND METHODS: The University of California, San Francisco Urologic Oncology database and the University of California, San Francisco Radiation Oncology database were queried for all patients with locally recurrent renal fossa recurrence. Only patients with recurrence of renal cell carcinoma in the renal fossa were included. Survival, complications and the use of adjuvant therapy in the form of intraoperative radiation therapy were noted. RESULTS: A total of 14 patients were treated for this lesion between 1990 and 2003. Mean time to recurrence was 40 months (range 5 to 180). Only 1 patient was symptomatic preoperatively, while in 13 disease had been detected on routine computerized tomography followup. Mean size of the recurrent tumor was 6.35 cm (range 2 to 17). 9 patients died of progressive, metastatic disease after a mean of 17 months (range 1 to 56) and 5 are alive with a mean survival of 66 months (range 14 to 86). The time to recurrence after nephrectomy approached statistical significance (p = 0.06) when comparing the patients who were alive vs those who died of disease. Additionally, there was no statistical difference in size of mass recurrence between these 2 groups. There was no difference in survival due to adjuvant intraoperative radiation therapy. Local fossa re-recurrence developed in 2 patients. Survival was 40% at 2 years and 30% at 5 years from surgery. Complications, including minor complications, occurred in 42% of patients and there was no perioperative mortality. CONCLUSIONS: Selected patients with isolated local recurrence in the renal fossa may have favorable and durable outcomes following surgical resection and possibly adjuvant intraoperative radiation therapyfor isolated renal fossa recurrence following radical nephrectomy. Development of novel and effective systemic therapy is needed in high risk patients with renal cancer.
机译:目的:在没有远处转移性疾病的肾窝中,肾细胞癌的局部复发是很少见的。该病的治疗可能具有挑战性,文献中仅有相对较少的系列报道。我们描述了在手术辅助放疗中进行手术切除的方法。材料与方法:查询所有局部复发性肾窝复发患者的加利福尼亚大学旧金山泌尿外科肿瘤学数据库和加利福尼亚大学旧金山泌尿外科肿瘤学数据库。仅纳入肾窝中肾细胞癌复发的患者。记录了生存期,并发症和术中放射治疗形式的辅助治疗的使用。结果:1990年至2003年间共治疗了14例患者。平均复发时间为40个月(5至180范围)。术前只有1例患者有症状,而常规的计算机断层扫描随访中发现13例疾病。复发肿瘤的平均大小为6.35厘米(范围2至17)。 9例患者在平均17个月(1至56范围)后死于进行性转移性疾病,5例还活着,平均生存期为66个月(14至86范围)。当比较活着的患者和死于疾病的患者时,肾切除术后的复发时间接近统计学显着性(p = 0.06)。此外,这两组之间的肿块复发的大小没有统计学差异。由于术中辅助放疗,生存期无差异。 2例患者发生局部窝复发。术后2年生存率为40%,5年生存率为30%。 42%的患者发生并发症,包括轻微并发症,并且没有围手术期死亡。结论:经选择的肾窝局部局限性复发患者在手术切除后可能会获得良好而持久的结果,并且可能接受辅助术中放疗以治疗根治性肾切除术后孤立的肾窝复发。高危肾癌患者需要开发新颖有效的全身疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号